Dandelion Health

Understanding the broader impact of a new drug class has historically taken many years and significant capital. As a result, much-needed treatments have taken longer than they should to get to patients. We are in a fascinating period when the emergence of the largest drug class we have ever seen is intersecting with rapid advancements in AI. Thanks to Fast Company for publishing an article written by our CEO Elliott Green on how and why these dual trends may lead to an unprecedented rate of innovation in cardiometabolic treatment. https://lnkd.in/gRKwQCSf

Is precision medicine poised to transform the use of GLP-1s in 2025? Considering 1 in 5 people won't lose weight with GLP-1 drugs, as well as the exorbitantly high cost of these drugs, we believe the push for precision medicine with GLP-1s will be a main focus for the pharma & healthcare industries in the year ahead. Check out this story in Precision Medicine Online from Caroline Hopkins Legaspi to learn more about the role AI and multimodal real-world data will play in 2025 when it comes to driving earlier identification of patients who are more likely to benefit from these high cost, high impact medications. https://lnkd.in/gKcvR5Ff #pharma #GLP1 #precisionmedicine #realworlddata #AI #weightloss

Are you a researcher interested in the impact of GLP-1s on cardiovascular risk reduction? Want to access rich multimodal data to explore this at a much more granular level than you can through claims data and structured EHR? Then this funding opportunity is for you! The American Heart Association has announced a call for proposals entitled: "Identifying Predictors of Cardiovascular Risk Reduction Among Individuals with Obesity and Cardiovascular Disease on GLP-1 Medications." Link below. It's up to $150k for one year and can be used to access Dandelion's longitudinal data on GLP-1 users, including labs, ECGs, echos, cardiac cath reports, and more. Please tag in colleagues who might be interested! https://bit.ly/4dI0iEJ And feel free to reach out to me directly with questions about Dandelion's GLP-1 data library. More detail here: https://lnkd.in/e-Ud_RRH

With the recent launch of our Clinical AI Marketplace, we’re also expanding our sales team! We’re looking to hire an ambitious and experienced Director of Sales, with a focus on selling to life science organizations. If you are excited about working at the forefront of clinical AI, driving strategic enterprise deals, and working with an amazing team, come join us! Location: NYC or Remote Please direct your interest to [email protected] JD: https://lnkd.in/gpH7pjRz

“We believe that our Clinical AI Marketplace’s ability to combine multimodal RWD with validated AI will empower life sciences companies to move faster, reduce development costs, and foster greater creativity.” Dandelion’s Head of Growth Nicholas Gossen shares his thoughts on the strategy, design, and potential impact of Dandelion’s Clinical AI Marketplace. Check out the full blog post on our website here: https://lnkd.in/gZRGC-gT 

What value can validated clinical AI combined with diverse, multimodal, and unstructured real-world data bring for pharma and for patients? The sky's the limit. Check out the latest from Emma with Fierce Healthcare on the launch of Dandelion’s Clinical AI Marketplace and the supporting proof of concept study we led with Pheiron's support: https://lnkd.in/gJGECCfU The study - leveraging our RWD + Pheiron’s validated AI - shows GLP-1s can reduce cardiovascular disease risk in a previously unstudied and clinically silent population. #AI #realworlddata #clinicaltrials #pharma #lifesci #HLTH24

Breaking news - today we launched results from a large study that uncovered how GLP-1 medications may help prevent cardiovascular disease for 44M previously unstudied U.S. patients. The study was conducted using a validated AI algorithm from Pheiron, accessible on our brand new Clinical AI Marketplace, which also launched today. To learn more about the mission-critical work we’re doing to help life sciences companies accelerate clinical development & commercialization at a fraction of the typical time & cost, check out this story from Deidre with CNN: https://lnkd.in/g5F-Dqxi To download the full research whitepaper, see the link in the comments. #GLPs #clinicaltrials #realworlddata #AI #digitalhealth #pharma

We are excited to share a new blog in collaboration with The SCAN Foundation that shares our learnings from a year of validating clinical AI algorithms. Together, we’ve evaluated AI tools for bias that is less commonly considered: bias across social determinants of health (SDoH) measures like median income, social vulnerability, and rural vs. urban populations. Dandelion Health and The SCAN Foundation believe AI can usher in a new age of precision medicine and clinical care, but only if it’s equitable for those who stand to gain the most: populations that have historically been underserved in clinical care. Learn more about our findings and our vision for the future in our latest blog below. Thanks so much for the phenomenal partnership from The SCAN Foundation Anika Heavener Sarita Mohanty, MD, MPH, MBA Natalie King Xenia Viragh Brendan Ahern from all those at Dandelion who were lucky enough to work on this Shivaani Prakash, MSc, PhD Ana-Vanessa “AV” Ploumpis Manqing L. Gonzalo Hernandez Nicholas Gossen Matthew Stewart, PhD Mara Alexeev Balazs Lengyel, MD Mathilde Williams Ross Bierbryer #healthcare #healthai #sdoh #healthequity https://lnkd.in/erS3sKxt

Are you attending the NLP Summit led by John Snow Labs from Sept. 24-26? We hope so! Join Dandelion and our Head of Engineering, Ross Bierbryer, who will be leading a keynote at the Summit entitled "Deidentifying Free-text Patient Notes: No Need for Tradeoffs." We're looking forward to a robust discussion on the challenges and opportunities of GenAI from other leading minds at Roche, Philips, Cedars-Sinai & more.  To learn more visit: https://lnkd.in/dnS8eFjb #NLPSummit #GenAI #HealthAI #HealthcareNLP #LLM #Precisionmedicine

There is so much hope resting on the opportunity for AI to change healthcare for the better. Still, it's validated AI, that's tested on a diverse and representative real-world data set, that provides the opportunity to transform traditional patient care into more equitable and personalized patient care. Dandelion Health is honored to be mentioned in this related article in Harvard Business Review. As an industry, we need to be talking more about best practices for prioritizing equity as essential to unbiased AI development. Thanks to Carol Cruickshank, Junaid Bajwa, and Cian Wade for including us. https://lnkd.in/g9x44DtW